SP-MHCI-0603-3
The SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) Replicase polyprotein 1ab Peptide (IEDB: 69392) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Replicase polyprotein Peptide, H-VLAWLYAAV-OH (Uniprot: P0DTD1 aa: 3467-3475) from JPT is produced under strict quality control and quality management.
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References:
Read References with JPT’s Antigen Peptides
SARS-CoV-2 Replicase polyprotein 1ab 3467-3475, VLAWLYAAV has been described in:
Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a., Antiviral Res, 2009 (PMID: 19748524)
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels., medRxiv, 2020 (PMID: 32793919)
Phenotype, specificity and avidity of antitumour CD8<sup>+</sup> T cells in melanoma., Nature, 2021 (PMID: 34290406)
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Covid-19 |
Layout: | Freeze-dried in glass vial |
Organism: | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Protein Name: | Replicase polyprotein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Information | Values |
---|---|
Sequence: | H-VLAWLYAAV-OH |
Specifications: | 9mer peptide as TFA salt |
Check our list of products, click and go.
Get a quote